A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

NCT06091254 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

822

Enrollment

INDUSTRY

Sponsor class

Conditions

Follicular Lymphoma (FL)

Interventions

DRUG: Odronextamab
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone/prednisolone
DRUG: Bendamustine

Sponsor

Regeneron Pharmaceuticals